Tuberculosis, Pulmonary
Showing 26 - 50 of 113
Tuberculosis, Pulmonary, Mycobacterium Tuberculosis Infection Trial in Kampala (Active TB case finding with linkage to
Recruiting
- Tuberculosis, Pulmonary
- Mycobacterium Tuberculosis Infection
- Active TB case finding with linkage to preventive therapy (ACF/TPT)
-
Kampala, UgandaWalimu
Jun 8, 2022
Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with
Not yet recruiting
- Tuberculosis, Pulmonary
- Short Regimen with Rifapentine 10mg/kg
- +3 more
-
Guiyang, Guizhou, China
- +5 more
May 28, 2022
Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)
Recruiting
- Tuberculosis, Pulmonary
- Sanfetrinem Cilexetil
- +2 more
-
Cape Town, Western Cape, South AfricaTASK Clinical Research Centre
May 19, 2022
Tuberculosis, Tuberculosis, Pulmonary Trial in Fair Lawn (1800 mg TBI-223, 2400mg TBI-223, 3000mg TBI-223)
Completed
- Tuberculosis
- Tuberculosis, Pulmonary
- 1800 mg TBI-223
- +3 more
-
Fair Lawn, New JerseyTKL Research, Inc.
Apr 13, 2022
Tuberculosis - Learning Effect of Parasites and Reinforcing
Enrolling by invitation
- Tuberculosis, Pulmonary
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 12, 2022
Childhood TB Sequel
Recruiting
- Tuberculosis, Pulmonary
-
Fajara, GambiaMRCG at LSHTM
Apr 5, 2022
Tuberculosis, Pulmonary Trial in Groningen (Azithromycin 250 mg)
Recruiting
- Tuberculosis, Pulmonary
- Azithromycin 250 mg
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 7, 2022
Assess the IGRA Positivity in Populations With a High TB Burden
Recruiting
- Tuberculosis, Pulmonary
-
Bloemfontein, South Africa
- +8 more
Apr 6, 2022
Tuberculosis, Pulmonary Trial in New Delhi, Tripura (RUTI®, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- RUTI®
- Placebo
-
New Delhi, India
- +1 more
Mar 24, 2022
HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)
Recruiting
- HIV/AIDS
- Tuberculosis, Pulmonary
- Biktarvy®
- TLD- fixed-drug combination single tablet
-
Durban, KwaZulu-Natal, South AfricaCAPRISA Springfield Clinical Research Site
Mar 14, 2022
Collision of Three Global Pandemics: Effect of Tuberculosis and
Not yet recruiting
- COVID-19
- +3 more
- Covid-19, TB and HIV diagnosis
- (no location specified)
Mar 2, 2022
Ethionamide and Ethionamide Sulfoxide in Patients Established on
Not yet recruiting
- Tuberculosis, Pulmonary
- Plasma samples
-
Cape Town, South AfricaTASK Applied Sciences
Feb 17, 2022
Tuberculosis, Pulmonary Trial in Ratchathewi (MetFORMIN 500 Mg Oral Tablet, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- MetFORMIN 500 Mg Oral Tablet
- Placebo
-
Ratchathewi, ฺBangkok, ThailandAngsana Phuphuakrat
Jan 30, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022
Blood Transcriptomic Signatures for Diagnosis of Active
Recruiting
- TUBERCULOSIS, PULMONARY
- ISIT-TB prototype
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
Jan 25, 2022
Tuberculosis, Tuberculosis, Pulmonary Trial in Cape Town (Multi-biomarker point-of-care test)
Recruiting
- Tuberculosis
- Tuberculosis, Pulmonary
- Multi-biomarker point-of-care test
-
Cape Town, Western Cape, South AfricaStellenbosch University
Jan 7, 2022
Tuberculosis, Pulmonary, HIV Seropositivity Trial in Douala (device, other, diagnostic test)
Completed
- Tuberculosis, Pulmonary
- HIV Seropositivity
- Tor Vergata Electronic Nose (TV eNose)
- +7 more
-
Douala, Littoral, CameroonCentre des Maladies Respiratoire
Dec 7, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide
Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of
Completed
- Tuberculosis
- +4 more
- 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021
Tuberculosis, Pulmonary Trial in Bengkayang (Vitamin D, Placebo)
Completed
- Tuberculosis, Pulmonary
- Vitamin D
- Placebo
-
Bengkayang, West Borneo, IndonesiaRS Bethesda
Oct 11, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021
Four Months Moxifloxacin Containing Daily Regimen Study Among
Not yet recruiting
- Tuberculosis, Pulmonary
- Isoniazid
- +4 more
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Sep 29, 2021
HIV Coinfection, Aids/Hiv Problem, Tuberculosis, Pulmonary Trial in Saint Petersburg (Interferon-Gamma)
Completed
- HIV Coinfection
- +5 more
-
Saint Petersburg, Saint-Petersburg, Russian Federation
- +1 more
Sep 23, 2021
Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- H56:IC31
- Placebo
-
Bellville, Cape Town, South Africa
- +5 more
Sep 27, 2021
Pulmonary Disease, Tuberculosis, Pulmonary, Tuberculosis Trial in San Antonio (TBAJ-876 10mg, TBAJ-876 25mg, TBAJ-876 50mg)
Active, not recruiting
- Pulmonary Disease
- +6 more
- TBAJ-876 10mg
- +8 more
-
San Antonio, TexasWorldwide Clinical Trials
Sep 2, 2021